Nature Genet:男性乳腺癌与RAD51B基因变异有关

2012-09-25 Beyond 生物谷

近日,一项最新研究旨在探究男性乳腺癌患者的基因变异情况,该研究进一步深入了解了乳腺癌疾病,每年在美国有几百人死于乳腺癌。 研究人员说,他们已经发现了另一个与男性乳腺癌的遗传变异,男性乳腺癌是一种罕见的疾病,每年在美国几百人死于该种疾病。 这一发现将立即改善男性乳腺癌治疗的改进。不过,寻找到更多的男性乳腺癌突变基因,我们可以了解该疾病的生物学信息,因此就能更好地了解如何最好地治疗男性乳腺癌。

近日,一项最新研究旨在探究男性乳腺癌患者的基因变异情况,该研究进一步深入了解了乳腺癌疾病,每年在美国有几百人死于乳腺癌。

研究人员说,他们已经发现了另一个与男性乳腺癌的遗传变异,男性乳腺癌是一种罕见的疾病,每年在美国几百人死于该种疾病。

这一发现将立即改善男性乳腺癌治疗的改进。不过,寻找到更多的男性乳腺癌突变基因,我们可以了解该疾病的生物学信息,因此就能更好地了解如何最好地治疗男性乳腺癌。

研究报告作者伦敦癌症研究所Nick Orr博士说,我们希望这些发现也将帮助我们更多地了解女性乳腺癌患者是如何发病的。根据美国癌症协会统计,男性乳癌的发病率比女性乳腺癌少100倍左右。

据估计,今年在美国乳腺癌诊断病例中约2,190人为男性,约有410人死亡。男性乳腺癌的预后于乳腺癌女性患者是相似的,去年公布的一项研究也证实,男性被诊断的平均年龄在70岁左右,女性发病年龄在62岁左右。

Orr解释:对于乳腺癌女性患者的发病在过去的几十年中已经取得了很大的进步。但我们很少知道是什么原因导致男性也患这种疾病。在这项新研究中,研究人员研究了823名乳腺癌男性患者的DNA和2795名未患这种疾病男性的DNA。

研究小组发现,20%的男性乳腺癌患者存在RAD51B基因变异,但只有15%的乳腺癌男性患者没有发现RAD51B基因变异。早期研究证实RAD51B的变异也与女性乳腺癌发病有关。相关研究发表在9月23日的Nature Genetics杂志上。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]
    2013-07-26 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]
    2013-07-21 cy0324
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]
    2013-02-08 canlab
  4. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]
    2013-02-15 syscxl
  6. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1879369, encodeId=8a1218e9369b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jul 26 13:30:00 CST 2013, time=2013-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048479, encodeId=a4da20484e930, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 21 21:30:00 CST 2013, time=2013-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733608, encodeId=73041e33608e4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Feb 08 16:30:00 CST 2013, time=2013-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685868, encodeId=2b9016858682b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Wed Jan 02 04:30:00 CST 2013, time=2013-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15071, encryptionId=5746150e104, topicName=RAD51)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fd024763623, createdName=syscxl, createdTime=Fri Feb 15 22:30:00 CST 2013, time=2013-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314119, encodeId=6da013141195a, content=<a href='/topic/show?id=b5e641e1279' target=_blank style='color:#2F92EE;'>#基因变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41712, encryptionId=b5e641e1279, topicName=基因变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342258, encodeId=13ce134225820, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590186, encodeId=0524159018671, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Thu Sep 27 07:30:00 CST 2012, time=2012-09-27, status=1, ipAttribution=)]